-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, Sinovac Biopharmaceutical Co.
, Ltd.
(hereinafter referred to as the "Company") developed a phase I clinical study of human interferon α2b spray successfully completed the first subject enrollment administration
.
Human interferon α2b spray is a two-class improved new drug independently developed by the company, which optimizes the dosage form and route of administration of the listed drug, increases the drug concentration at the lesion site through targeted topical administration, is easy to use and carry, has good patient compliance, and has obvious clinical advantages
.
The company's human interferon alpha 2b spray is indicated for the treatment of initial or recurrent cutaneous herpes simplex (cold sores and genital herpes)
caused by viruses.